Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMR vs MRNA✓SelectedUSD · MRNASMR vs MRNA performance historyLatest closeAs of-11.81%11/20
Stock and ETF performance explorer

SMR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-67.7%
MRNA return
+323.5%
Excess return
-391.2%
Maximum drawdown
-75.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-11.8%-2.2%-9.6%-11.7%
7D-27.9%-12.7%-15.2%-27.2%
30D-38.9%-20.7%-18.2%-37.9%
3M-63.0%+46.3%-109.2%-63.8%
6M-67.7%+305.2%-372.9%-73.0%
All-67.7%+323.5%-391.2%-73.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling